Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry eye, and the Others one is evaporative dry eye. Dry eye syndrome is one of the most common eye disorders around the world and is particularly common in the geriatric demographic. Reduction in the production of tears due to aging is the primary cause of dry eye syndrome among the elderly.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Drugs and Devices Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Drugs and Devices Treatment. This report contains market size and forecasts of Dry Eye Drugs and Devices Treatment in global, including the following market information:
Global Dry Eye Drugs and Devices Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Dry Eye Drugs and Devices Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominates the global market. The region is projected to account for a significant share of the global dry eye drugs and devices treatment market during the forecast period due to a high incidence of dry eye disease among the American population.
We surveyed the Dry Eye Drugs and Devices Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dry Eye Drugs and Devices Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Dry Eye Drugs and Devices Treatment Market Segment Percentages, by Type, 2022 (%)
Antibiotic Drops
Hormone Drops
Artificial Tears
Others
Global Dry Eye Drugs and Devices Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Dry Eye Drugs and Devices Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Dry Eye Drugs and Devices Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Dry Eye Drugs and Devices Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dry Eye Drugs and Devices Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dry Eye Drugs and Devices Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Merck
Johnson & Johnson
EyeGate Pharmaceuticals
Allergan
Takeda
Jianfeng Group
Bausch Health
Santen Pharmaceutical
Senju Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dry Eye Drugs and Devices Treatment, market overview.
Chapter 2: Global Dry Eye Drugs and Devices Treatment market size in revenue.
Chapter 3: Detailed analysis of Dry Eye Drugs and Devices Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Eye Drugs and Devices Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dry Eye Drugs and Devices Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dry Eye Drugs and Devices Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dry Eye Drugs and Devices Treatment Overall Market Size
2.1 Global Dry Eye Drugs and Devices Treatment Market Size: 2022 VS 2030
2.2 Global Dry Eye Drugs and Devices Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dry Eye Drugs and Devices Treatment Players in Global Market
3.2 Top Global Dry Eye Drugs and Devices Treatment Companies Ranked by Revenue
3.3 Global Dry Eye Drugs and Devices Treatment Revenue by Companies
3.4 Top 3 and Top 5 Dry Eye Drugs and Devices Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Dry Eye Drugs and Devices Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dry Eye Drugs and Devices Treatment Players in Global Market
3.6.1 List of Global Tier 1 Dry Eye Drugs and Devices Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Dry Eye Drugs and Devices Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Dry Eye Drugs and Devices Treatment Market Size Markets, 2022 & 2030
4.1.2 Antibiotic Drops
4.1.3 Hormone Drops
4.1.4 Artificial Tears
4.1.5 Others
4.2 By Type - Global Dry Eye Drugs and Devices Treatment Revenue & Forecasts
4.2.1 By Type - Global Dry Eye Drugs and Devices Treatment Revenue, 2018-2023
4.2.2 By Type - Global Dry Eye Drugs and Devices Treatment Revenue, 2024-2030
4.2.3 By Type - Global Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dry Eye Drugs and Devices Treatment Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Dry Eye Drugs and Devices Treatment Revenue & Forecasts
5.2.1 By Application - Global Dry Eye Drugs and Devices Treatment Revenue, 2018-2023
5.2.2 By Application - Global Dry Eye Drugs and Devices Treatment Revenue, 2024-2030
5.2.3 By Application - Global Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Dry Eye Drugs and Devices Treatment Market Size, 2022 & 2030
6.2 By Region - Global Dry Eye Drugs and Devices Treatment Revenue & Forecasts
6.2.1 By Region - Global Dry Eye Drugs and Devices Treatment Revenue, 2018-2023
6.2.2 By Region - Global Dry Eye Drugs and Devices Treatment Revenue, 2024-2030
6.2.3 By Region - Global Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Dry Eye Drugs and Devices Treatment Revenue, 2018-2030
6.3.2 US Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.3.3 Canada Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.3.4 Mexico Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Dry Eye Drugs and Devices Treatment Revenue, 2018-2030
6.4.2 Germany Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.4.3 France Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.4.4 U.K. Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.4.5 Italy Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.4.6 Russia Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.4.8 Benelux Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Dry Eye Drugs and Devices Treatment Revenue, 2018-2030
6.5.2 China Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.5.3 Japan Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.5.4 South Korea Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.5.6 India Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Dry Eye Drugs and Devices Treatment Revenue, 2018-2030
6.6.2 Brazil Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.6.3 Argentina Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dry Eye Drugs and Devices Treatment Revenue, 2018-2030
6.7.2 Turkey Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.7.3 Israel Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
6.7.5 UAE Dry Eye Drugs and Devices Treatment Market Size, 2018-2030
7 Dry Eye Drugs and Devices Treatment Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Dry Eye Drugs and Devices Treatment Major Product Offerings
7.1.4 Novartis Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Dry Eye Drugs and Devices Treatment Major Product Offerings
7.2.4 Merck Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Dry Eye Drugs and Devices Treatment Major Product Offerings
7.3.4 Johnson & Johnson Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 EyeGate Pharmaceuticals
7.4.1 EyeGate Pharmaceuticals Company Summary
7.4.2 EyeGate Pharmaceuticals Business Overview
7.4.3 EyeGate Pharmaceuticals Dry Eye Drugs and Devices Treatment Major Product Offerings
7.4.4 EyeGate Pharmaceuticals Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.4.5 EyeGate Pharmaceuticals Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Dry Eye Drugs and Devices Treatment Major Product Offerings
7.5.4 Allergan Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.5.5 Allergan Key News & Latest Developments
7.6 Takeda
7.6.1 Takeda Company Summary
7.6.2 Takeda Business Overview
7.6.3 Takeda Dry Eye Drugs and Devices Treatment Major Product Offerings
7.6.4 Takeda Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.6.5 Takeda Key News & Latest Developments
7.7 Jianfeng Group
7.7.1 Jianfeng Group Company Summary
7.7.2 Jianfeng Group Business Overview
7.7.3 Jianfeng Group Dry Eye Drugs and Devices Treatment Major Product Offerings
7.7.4 Jianfeng Group Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.7.5 Jianfeng Group Key News & Latest Developments
7.8 Bausch Health
7.8.1 Bausch Health Company Summary
7.8.2 Bausch Health Business Overview
7.8.3 Bausch Health Dry Eye Drugs and Devices Treatment Major Product Offerings
7.8.4 Bausch Health Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.8.5 Bausch Health Key News & Latest Developments
7.9 Santen Pharmaceutical
7.9.1 Santen Pharmaceutical Company Summary
7.9.2 Santen Pharmaceutical Business Overview
7.9.3 Santen Pharmaceutical Dry Eye Drugs and Devices Treatment Major Product Offerings
7.9.4 Santen Pharmaceutical Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.9.5 Santen Pharmaceutical Key News & Latest Developments
7.10 Senju Pharmaceutical
7.10.1 Senju Pharmaceutical Company Summary
7.10.2 Senju Pharmaceutical Business Overview
7.10.3 Senju Pharmaceutical Dry Eye Drugs and Devices Treatment Major Product Offerings
7.10.4 Senju Pharmaceutical Dry Eye Drugs and Devices Treatment Revenue in Global Market (2018-2023)
7.10.5 Senju Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Dry Eye Drugs and Devices Treatment Market Opportunities & Trends in Global Market
Table 2. Dry Eye Drugs and Devices Treatment Market Drivers in Global Market
Table 3. Dry Eye Drugs and Devices Treatment Market Restraints in Global Market
Table 4. Key Players of Dry Eye Drugs and Devices Treatment in Global Market
Table 5. Top Dry Eye Drugs and Devices Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Dry Eye Drugs and Devices Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Dry Eye Drugs and Devices Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Dry Eye Drugs and Devices Treatment Product Type
Table 9. List of Global Tier 1 Dry Eye Drugs and Devices Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dry Eye Drugs and Devices Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Dry Eye Drugs and Devices Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Dry Eye Drugs and Devices Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Dry Eye Drugs and Devices Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Dry Eye Drugs and Devices Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Dry Eye Drugs and Devices Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Dry Eye Drugs and Devices Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2024-2030
Table 30. Novartis Company Summary
Table 31. Novartis Dry Eye Drugs and Devices Treatment Product Offerings
Table 32. Novartis Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Dry Eye Drugs and Devices Treatment Product Offerings
Table 36. Merck Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Dry Eye Drugs and Devices Treatment Product Offerings
Table 40. Johnson & Johnson Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. EyeGate Pharmaceuticals Company Summary
Table 43. EyeGate Pharmaceuticals Dry Eye Drugs and Devices Treatment Product Offerings
Table 44. EyeGate Pharmaceuticals Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. EyeGate Pharmaceuticals Key News & Latest Developments
Table 46. Allergan Company Summary
Table 47. Allergan Dry Eye Drugs and Devices Treatment Product Offerings
Table 48. Allergan Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Allergan Key News & Latest Developments
Table 50. Takeda Company Summary
Table 51. Takeda Dry Eye Drugs and Devices Treatment Product Offerings
Table 52. Takeda Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Takeda Key News & Latest Developments
Table 54. Jianfeng Group Company Summary
Table 55. Jianfeng Group Dry Eye Drugs and Devices Treatment Product Offerings
Table 56. Jianfeng Group Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Jianfeng Group Key News & Latest Developments
Table 58. Bausch Health Company Summary
Table 59. Bausch Health Dry Eye Drugs and Devices Treatment Product Offerings
Table 60. Bausch Health Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Bausch Health Key News & Latest Developments
Table 62. Santen Pharmaceutical Company Summary
Table 63. Santen Pharmaceutical Dry Eye Drugs and Devices Treatment Product Offerings
Table 64. Santen Pharmaceutical Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Santen Pharmaceutical Key News & Latest Developments
Table 66. Senju Pharmaceutical Company Summary
Table 67. Senju Pharmaceutical Dry Eye Drugs and Devices Treatment Product Offerings
Table 68. Senju Pharmaceutical Dry Eye Drugs and Devices Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Senju Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Dry Eye Drugs and Devices Treatment Segment by Type in 2022
Figure 2. Dry Eye Drugs and Devices Treatment Segment by Application in 2022
Figure 3. Global Dry Eye Drugs and Devices Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dry Eye Drugs and Devices Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Dry Eye Drugs and Devices Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dry Eye Drugs and Devices Treatment Revenue in 2022
Figure 8. By Type - Global Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 16. US Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 20. Germany Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 28. China Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Dry Eye Drugs and Devices Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Dry Eye Drugs and Devices Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. Novartis Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. EyeGate Pharmaceuticals Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Allergan Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Takeda Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Jianfeng Group Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bausch Health Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Santen Pharmaceutical Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Senju Pharmaceutical Dry Eye Drugs and Devices Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
